chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 40.0
Sex: M
Vaccine: TD
Symptoms: Injection site swelling, Injection site warmth, Pain, Pyrexia
Clinical narrative: The site of administration of the tetanus (we unsure if TD or Tdap) was on the back/bottom of the arm (normal SQ administration). Night of administration the injection site was sore, red and hard, pt also reported having fever and headaches which continue. The next morning the red area around injection site was considerably larger, warm and painful on movement. Doctor was notified and stated that the patient is probably having a reaction to the vaccine itself. Pictures of site was taken that shows the injection site on the posterior aspect of arm and length/width of redness/swelling. Friday evening the red site was larger and surpassed the markings made from the evening before. Saturday evening, redness and swelling has progressed to majority of upper arm with significant pain. He has been taking ibuprofen and Benadryl to alleviate some of the discomfort. Plan is when he returns Mon. night he will be going back to the doctor's office for intervention on Tuesday.
Age: 34.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Dysarthria, Dysphemia, Hypoaesthesia, Hypoaesthesia facial, Nuclear magnetic resonance imaging normal
Clinical narrative: Acute onset of stuttering and slurring of speech with difficulty with word pronunciation.  Left sided facial numbness and left lower extremity weakness.   Facial and leg symptoms improved over several hours.  Speech difficulty is progressive improving but still not fully resolved.
Age: 34.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Speech disorder, Stress
Clinical narrative: Acute onset of stuttering and slurring of speech with difficulty with word pronunciation.  Left sided facial numbness and left lower extremity weakness.   Facial and leg symptoms improved over several hours.  Speech difficulty is progressive improving but still not fully resolved.
Age: 16.0
Sex: F
Vaccine: DTAP, HEPA, HPVX
Symptoms: Diarrhoea, Oedema peripheral, Vomiting
Clinical narrative: Evening of shot arm swelling began.  By 6pm following evening vomiting (6 times) and diarrhea began and lasted until 6am.
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Facial palsy
Clinical narrative: Bell's Palsy
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: L arm-Redness, warmth inferior to deltoid, no drainage, no streaking toward shoulder all dependent signs to deltoid
Age: 0.63
Sex: F
Vaccine: FLUX(H1N1)
Symptoms: Blood test normal, Electroencephalogram, Staring, Unresponsive to stimuli
Clinical narrative: Patient stared off unblinking & looked frozen.  I noticed this, looked into her face & loudly said her name w/no response. She wasn't blue. I put my hand on cheek (not cold) & again said her name loudly.  She slowly responded by looking around.  She looked dazed.  I took her to see Dr. He did exam & blood work which were normal.  2/26/10 EEG was performed, waiting to speak w/neurologist now.  There have been other times in the past month where she has "zoned out" unblinking, but nothing this severe.  She received 1st half of H1N1 vaccine on 1/27/10.  She weighed 6 lbs 11 ounces at birth, was delivered about 1 1/2 weeks early & has no siblings.
Age: 37.0
Sex: F
Vaccine: DTAP
Symptoms: Injection site pain, Injection site swelling, Injection site warmth, Pain in extremity
Clinical narrative: Since vaccination pt. reports left arm pain travelling to her fingertips. Patient states area of injection is swollen, tender, not red but a little hot to touch.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Burning sensation, Pain, Pruritus
Clinical narrative: itching, burning, pain, soreness back and left side and abdomen
Age: 0.18
Sex: F
Vaccine: RV5
Symptoms: Ascites, Biopsy, Biopsy skin abnormal, Blood thyroid stimulating hormone increased, Bone marrow transplant
Clinical narrative: Information has been received from a physician concerning a 2 month old female patient with allergy to ZOSYN and penicillin allergy. It was reported that the patient was born via normal spontaneous vaginal delivery at 40 weeks, pregnancy was uncomplicated, patient's mother only gained 9# and the patient's parents are first cousins. On 28-JUL-2008 the patient was vaccinated with one dose of ROTATEQ (Lot # 660682/0547X). Concomitant vaccines included ACTHIB (Lot # UF446AA), PREVNAR (Lot # C45721H) and PEDIARIX (Lot # AC21B182AA). It was reported that the patient was admitted to hospital for failure thrive in October 2008 and was transferred to another hospital in November 2008. The patient was found to be rotavirus Ag positive and subsequently was diagnosed with Severe Combined Immune Deficiency Disease (SCID). The patient underwent a bone marrow transplant x2 with chronic rotavirus shedding/infection. The discharge summary and extensive medical records were received from 02-NOV-2008 to 25-AUG-2009. The final diagnosis was SCID (IL7 mutation, T cell negative, NE cell positive and B cells +1); Pneumocystitis carinii pneumonia (PCP); rotavirus, T cell immunodeficiency; Total Parenteral Nutrition (TPN) dependent; Failure to Thrive (FTT); oral aversion; global developmental delay, improving. The events resulted in extremely long complicated hospitalization. The patient was seen at outlying hospital and was also diagnosed with Urinary Tract Infection (UTI), dehydration, elevated TSH/hypothyroidism. Endocrine consult was done. The patient developed respiratory problems with hazy lungs. Sweat test borderline for CF was done. There were severe episodes of cough with desaturation. The endoscopy revealed immature larynx and esophagitis. The patient was transferred to higher level of care. The diagnosis there was PCP and persistent rotavirus infection from November 2008 to July 2009. There were multiple consults done including genetics. Eventually diagnosis of SCID and the treatment was bone marrow transplants x 2 and chemotherapy. The patient developed large duodenal hematoma secondary to endoscopy. Also developed rash and skin desquamation, and biopsy confirmed graft versus host disease (GVDH) (grade 2); gallbladder sludge, pancreatitis, ascites, delayed gastric emptying and unable to tolerate oral feeding, endoscopy confirmed gut GVDH grade 2. The treatment with multiple courses of antibiotics, steroids, IVIG, chemotherapy, platelet (PLT) and packed red blood cells (PRBC) transfusions. The parent genetic testing indicated both carriers of SCID receptor gene. Eventually, the patient was transferred to specialized hospital for continued rehabilitation. No further information is available.
Age: 0.18
Sex: F
Vaccine: RV5
Symptoms: Chemotherapy, Cholelithiasis, Combined immunodeficiency, Cough, Dehydration
Clinical narrative: Information has been received from a physician concerning a 2 month old female patient with allergy to ZOSYN and penicillin allergy. It was reported that the patient was born via normal spontaneous vaginal delivery at 40 weeks, pregnancy was uncomplicated, patient's mother only gained 9# and the patient's parents are first cousins. On 28-JUL-2008 the patient was vaccinated with one dose of ROTATEQ (Lot # 660682/0547X). Concomitant vaccines included ACTHIB (Lot # UF446AA), PREVNAR (Lot # C45721H) and PEDIARIX (Lot # AC21B182AA). It was reported that the patient was admitted to hospital for failure thrive in October 2008 and was transferred to another hospital in November 2008. The patient was found to be rotavirus Ag positive and subsequently was diagnosed with Severe Combined Immune Deficiency Disease (SCID). The patient underwent a bone marrow transplant x2 with chronic rotavirus shedding/infection. The discharge summary and extensive medical records were received from 02-NOV-2008 to 25-AUG-2009. The final diagnosis was SCID (IL7 mutation, T cell negative, NE cell positive and B cells +1); Pneumocystitis carinii pneumonia (PCP); rotavirus, T cell immunodeficiency; Total Parenteral Nutrition (TPN) dependent; Failure to Thrive (FTT); oral aversion; global developmental delay, improving. The events resulted in extremely long complicated hospitalization. The patient was seen at outlying hospital and was also diagnosed with Urinary Tract Infection (UTI), dehydration, elevated TSH/hypothyroidism. Endocrine consult was done. The patient developed respiratory problems with hazy lungs. Sweat test borderline for CF was done. There were severe episodes of cough with desaturation. The endoscopy revealed immature larynx and esophagitis. The patient was transferred to higher level of care. The diagnosis there was PCP and persistent rotavirus infection from November 2008 to July 2009. There were multiple consults done including genetics. Eventually diagnosis of SCID and the treatment was bone marrow transplants x 2 and chemotherapy. The patient developed large duodenal hematoma secondary to endoscopy. Also developed rash and skin desquamation, and biopsy confirmed graft versus host disease (GVDH) (grade 2); gallbladder sludge, pancreatitis, ascites, delayed gastric emptying and unable to tolerate oral feeding, endoscopy confirmed gut GVDH grade 2. The treatment with multiple courses of antibiotics, steroids, IVIG, chemotherapy, platelet (PLT) and packed red blood cells (PRBC) transfusions. The parent genetic testing indicated both carriers of SCID receptor gene. Eventually, the patient was transferred to specialized hospital for continued rehabilitation. No further information is available.
Age: 0.18
Sex: F
Vaccine: RV5
Symptoms: Developmental delay, Diet refusal, Endoscopy abnormal, Failure to thrive, Feeding disorder of infancy or early childhood
Clinical narrative: Information has been received from a physician concerning a 2 month old female patient with allergy to ZOSYN and penicillin allergy. It was reported that the patient was born via normal spontaneous vaginal delivery at 40 weeks, pregnancy was uncomplicated, patient's mother only gained 9# and the patient's parents are first cousins. On 28-JUL-2008 the patient was vaccinated with one dose of ROTATEQ (Lot # 660682/0547X). Concomitant vaccines included ACTHIB (Lot # UF446AA), PREVNAR (Lot # C45721H) and PEDIARIX (Lot # AC21B182AA). It was reported that the patient was admitted to hospital for failure thrive in October 2008 and was transferred to another hospital in November 2008. The patient was found to be rotavirus Ag positive and subsequently was diagnosed with Severe Combined Immune Deficiency Disease (SCID). The patient underwent a bone marrow transplant x2 with chronic rotavirus shedding/infection. The discharge summary and extensive medical records were received from 02-NOV-2008 to 25-AUG-2009. The final diagnosis was SCID (IL7 mutation, T cell negative, NE cell positive and B cells +1); Pneumocystitis carinii pneumonia (PCP); rotavirus, T cell immunodeficiency; Total Parenteral Nutrition (TPN) dependent; Failure to Thrive (FTT); oral aversion; global developmental delay, improving. The events resulted in extremely long complicated hospitalization. The patient was seen at outlying hospital and was also diagnosed with Urinary Tract Infection (UTI), dehydration, elevated TSH/hypothyroidism. Endocrine consult was done. The patient developed respiratory problems with hazy lungs. Sweat test borderline for CF was done. There were severe episodes of cough with desaturation. The endoscopy revealed immature larynx and esophagitis. The patient was transferred to higher level of care. The diagnosis there was PCP and persistent rotavirus infection from November 2008 to July 2009. There were multiple consults done including genetics. Eventually diagnosis of SCID and the treatment was bone marrow transplants x 2 and chemotherapy. The patient developed large duodenal hematoma secondary to endoscopy. Also developed rash and skin desquamation, and biopsy confirmed graft versus host disease (GVDH) (grade 2); gallbladder sludge, pancreatitis, ascites, delayed gastric emptying and unable to tolerate oral feeding, endoscopy confirmed gut GVDH grade 2. The treatment with multiple courses of antibiotics, steroids, IVIG, chemotherapy, platelet (PLT) and packed red blood cells (PRBC) transfusions. The parent genetic testing indicated both carriers of SCID receptor gene. Eventually, the patient was transferred to specialized hospital for continued rehabilitation. No further information is available.
Age: 0.18
Sex: F
Vaccine: RV5
Symptoms: Food aversion, Gene mutation identification test positive, Graft versus host disease, Haematoma, Hypothyroidism
Clinical narrative: Information has been received from a physician concerning a 2 month old female patient with allergy to ZOSYN and penicillin allergy. It was reported that the patient was born via normal spontaneous vaginal delivery at 40 weeks, pregnancy was uncomplicated, patient's mother only gained 9# and the patient's parents are first cousins. On 28-JUL-2008 the patient was vaccinated with one dose of ROTATEQ (Lot # 660682/0547X). Concomitant vaccines included ACTHIB (Lot # UF446AA), PREVNAR (Lot # C45721H) and PEDIARIX (Lot # AC21B182AA). It was reported that the patient was admitted to hospital for failure thrive in October 2008 and was transferred to another hospital in November 2008. The patient was found to be rotavirus Ag positive and subsequently was diagnosed with Severe Combined Immune Deficiency Disease (SCID). The patient underwent a bone marrow transplant x2 with chronic rotavirus shedding/infection. The discharge summary and extensive medical records were received from 02-NOV-2008 to 25-AUG-2009. The final diagnosis was SCID (IL7 mutation, T cell negative, NE cell positive and B cells +1); Pneumocystitis carinii pneumonia (PCP); rotavirus, T cell immunodeficiency; Total Parenteral Nutrition (TPN) dependent; Failure to Thrive (FTT); oral aversion; global developmental delay, improving. The events resulted in extremely long complicated hospitalization. The patient was seen at outlying hospital and was also diagnosed with Urinary Tract Infection (UTI), dehydration, elevated TSH/hypothyroidism. Endocrine consult was done. The patient developed respiratory problems with hazy lungs. Sweat test borderline for CF was done. There were severe episodes of cough with desaturation. The endoscopy revealed immature larynx and esophagitis. The patient was transferred to higher level of care. The diagnosis there was PCP and persistent rotavirus infection from November 2008 to July 2009. There were multiple consults done including genetics. Eventually diagnosis of SCID and the treatment was bone marrow transplants x 2 and chemotherapy. The patient developed large duodenal hematoma secondary to endoscopy. Also developed rash and skin desquamation, and biopsy confirmed graft versus host disease (GVDH) (grade 2); gallbladder sludge, pancreatitis, ascites, delayed gastric emptying and unable to tolerate oral feeding, endoscopy confirmed gut GVDH grade 2. The treatment with multiple courses of antibiotics, steroids, IVIG, chemotherapy, platelet (PLT) and packed red blood cells (PRBC) transfusions. The parent genetic testing indicated both carriers of SCID receptor gene. Eventually, the patient was transferred to specialized hospital for continued rehabilitation. No further information is available.
Age: 0.18
Sex: F
Vaccine: RV5
Symptoms: Immature larynx, Immunoglobulin therapy, Impaired gastric emptying, Lung disorder, Oesophagitis
Clinical narrative: Information has been received from a physician concerning a 2 month old female patient with allergy to ZOSYN and penicillin allergy. It was reported that the patient was born via normal spontaneous vaginal delivery at 40 weeks, pregnancy was uncomplicated, patient's mother only gained 9# and the patient's parents are first cousins. On 28-JUL-2008 the patient was vaccinated with one dose of ROTATEQ (Lot # 660682/0547X). Concomitant vaccines included ACTHIB (Lot # UF446AA), PREVNAR (Lot # C45721H) and PEDIARIX (Lot # AC21B182AA). It was reported that the patient was admitted to hospital for failure thrive in October 2008 and was transferred to another hospital in November 2008. The patient was found to be rotavirus Ag positive and subsequently was diagnosed with Severe Combined Immune Deficiency Disease (SCID). The patient underwent a bone marrow transplant x2 with chronic rotavirus shedding/infection. The discharge summary and extensive medical records were received from 02-NOV-2008 to 25-AUG-2009. The final diagnosis was SCID (IL7 mutation, T cell negative, NE cell positive and B cells +1); Pneumocystitis carinii pneumonia (PCP); rotavirus, T cell immunodeficiency; Total Parenteral Nutrition (TPN) dependent; Failure to Thrive (FTT); oral aversion; global developmental delay, improving. The events resulted in extremely long complicated hospitalization. The patient was seen at outlying hospital and was also diagnosed with Urinary Tract Infection (UTI), dehydration, elevated TSH/hypothyroidism. Endocrine consult was done. The patient developed respiratory problems with hazy lungs. Sweat test borderline for CF was done. There were severe episodes of cough with desaturation. The endoscopy revealed immature larynx and esophagitis. The patient was transferred to higher level of care. The diagnosis there was PCP and persistent rotavirus infection from November 2008 to July 2009. There were multiple consults done including genetics. Eventually diagnosis of SCID and the treatment was bone marrow transplants x 2 and chemotherapy. The patient developed large duodenal hematoma secondary to endoscopy. Also developed rash and skin desquamation, and biopsy confirmed graft versus host disease (GVDH) (grade 2); gallbladder sludge, pancreatitis, ascites, delayed gastric emptying and unable to tolerate oral feeding, endoscopy confirmed gut GVDH grade 2. The treatment with multiple courses of antibiotics, steroids, IVIG, chemotherapy, platelet (PLT) and packed red blood cells (PRBC) transfusions. The parent genetic testing indicated both carriers of SCID receptor gene. Eventually, the patient was transferred to specialized hospital for continued rehabilitation. No further information is available.
Age: 0.18
Sex: F
Vaccine: RV5
Symptoms: Packed red blood cell transfusion, Pancreatitis, Parenteral nutrition, Platelet transfusion, Pneumocystis jiroveci pneumonia
Clinical narrative: Information has been received from a physician concerning a 2 month old female patient with allergy to ZOSYN and penicillin allergy. It was reported that the patient was born via normal spontaneous vaginal delivery at 40 weeks, pregnancy was uncomplicated, patient's mother only gained 9# and the patient's parents are first cousins. On 28-JUL-2008 the patient was vaccinated with one dose of ROTATEQ (Lot # 660682/0547X). Concomitant vaccines included ACTHIB (Lot # UF446AA), PREVNAR (Lot # C45721H) and PEDIARIX (Lot # AC21B182AA). It was reported that the patient was admitted to hospital for failure thrive in October 2008 and was transferred to another hospital in November 2008. The patient was found to be rotavirus Ag positive and subsequently was diagnosed with Severe Combined Immune Deficiency Disease (SCID). The patient underwent a bone marrow transplant x2 with chronic rotavirus shedding/infection. The discharge summary and extensive medical records were received from 02-NOV-2008 to 25-AUG-2009. The final diagnosis was SCID (IL7 mutation, T cell negative, NE cell positive and B cells +1); Pneumocystitis carinii pneumonia (PCP); rotavirus, T cell immunodeficiency; Total Parenteral Nutrition (TPN) dependent; Failure to Thrive (FTT); oral aversion; global developmental delay, improving. The events resulted in extremely long complicated hospitalization. The patient was seen at outlying hospital and was also diagnosed with Urinary Tract Infection (UTI), dehydration, elevated TSH/hypothyroidism. Endocrine consult was done. The patient developed respiratory problems with hazy lungs. Sweat test borderline for CF was done. There were severe episodes of cough with desaturation. The endoscopy revealed immature larynx and esophagitis. The patient was transferred to higher level of care. The diagnosis there was PCP and persistent rotavirus infection from November 2008 to July 2009. There were multiple consults done including genetics. Eventually diagnosis of SCID and the treatment was bone marrow transplants x 2 and chemotherapy. The patient developed large duodenal hematoma secondary to endoscopy. Also developed rash and skin desquamation, and biopsy confirmed graft versus host disease (GVDH) (grade 2); gallbladder sludge, pancreatitis, ascites, delayed gastric emptying and unable to tolerate oral feeding, endoscopy confirmed gut GVDH grade 2. The treatment with multiple courses of antibiotics, steroids, IVIG, chemotherapy, platelet (PLT) and packed red blood cells (PRBC) transfusions. The parent genetic testing indicated both carriers of SCID receptor gene. Eventually, the patient was transferred to specialized hospital for continued rehabilitation. No further information is available.
Age: 0.18
Sex: F
Vaccine: RV5
Symptoms: Post procedural haematoma, Rash, Respiratory disorder, Rotavirus infection, Rotavirus test positive
Clinical narrative: Information has been received from a physician concerning a 2 month old female patient with allergy to ZOSYN and penicillin allergy. It was reported that the patient was born via normal spontaneous vaginal delivery at 40 weeks, pregnancy was uncomplicated, patient's mother only gained 9# and the patient's parents are first cousins. On 28-JUL-2008 the patient was vaccinated with one dose of ROTATEQ (Lot # 660682/0547X). Concomitant vaccines included ACTHIB (Lot # UF446AA), PREVNAR (Lot # C45721H) and PEDIARIX (Lot # AC21B182AA). It was reported that the patient was admitted to hospital for failure thrive in October 2008 and was transferred to another hospital in November 2008. The patient was found to be rotavirus Ag positive and subsequently was diagnosed with Severe Combined Immune Deficiency Disease (SCID). The patient underwent a bone marrow transplant x2 with chronic rotavirus shedding/infection. The discharge summary and extensive medical records were received from 02-NOV-2008 to 25-AUG-2009. The final diagnosis was SCID (IL7 mutation, T cell negative, NE cell positive and B cells +1); Pneumocystitis carinii pneumonia (PCP); rotavirus, T cell immunodeficiency; Total Parenteral Nutrition (TPN) dependent; Failure to Thrive (FTT); oral aversion; global developmental delay, improving. The events resulted in extremely long complicated hospitalization. The patient was seen at outlying hospital and was also diagnosed with Urinary Tract Infection (UTI), dehydration, elevated TSH/hypothyroidism. Endocrine consult was done. The patient developed respiratory problems with hazy lungs. Sweat test borderline for CF was done. There were severe episodes of cough with desaturation. The endoscopy revealed immature larynx and esophagitis. The patient was transferred to higher level of care. The diagnosis there was PCP and persistent rotavirus infection from November 2008 to July 2009. There were multiple consults done including genetics. Eventually diagnosis of SCID and the treatment was bone marrow transplants x 2 and chemotherapy. The patient developed large duodenal hematoma secondary to endoscopy. Also developed rash and skin desquamation, and biopsy confirmed graft versus host disease (GVDH) (grade 2); gallbladder sludge, pancreatitis, ascites, delayed gastric emptying and unable to tolerate oral feeding, endoscopy confirmed gut GVDH grade 2. The treatment with multiple courses of antibiotics, steroids, IVIG, chemotherapy, platelet (PLT) and packed red blood cells (PRBC) transfusions. The parent genetic testing indicated both carriers of SCID receptor gene. Eventually, the patient was transferred to specialized hospital for continued rehabilitation. No further information is available.
Age: 0.18
Sex: F
Vaccine: RV5
Symptoms: Skin exfoliation, Sweat test, Urinary tract infection
Clinical narrative: Information has been received from a physician concerning a 2 month old female patient with allergy to ZOSYN and penicillin allergy. It was reported that the patient was born via normal spontaneous vaginal delivery at 40 weeks, pregnancy was uncomplicated, patient's mother only gained 9# and the patient's parents are first cousins. On 28-JUL-2008 the patient was vaccinated with one dose of ROTATEQ (Lot # 660682/0547X). Concomitant vaccines included ACTHIB (Lot # UF446AA), PREVNAR (Lot # C45721H) and PEDIARIX (Lot # AC21B182AA). It was reported that the patient was admitted to hospital for failure thrive in October 2008 and was transferred to another hospital in November 2008. The patient was found to be rotavirus Ag positive and subsequently was diagnosed with Severe Combined Immune Deficiency Disease (SCID). The patient underwent a bone marrow transplant x2 with chronic rotavirus shedding/infection. The discharge summary and extensive medical records were received from 02-NOV-2008 to 25-AUG-2009. The final diagnosis was SCID (IL7 mutation, T cell negative, NE cell positive and B cells +1); Pneumocystitis carinii pneumonia (PCP); rotavirus, T cell immunodeficiency; Total Parenteral Nutrition (TPN) dependent; Failure to Thrive (FTT); oral aversion; global developmental delay, improving. The events resulted in extremely long complicated hospitalization. The patient was seen at outlying hospital and was also diagnosed with Urinary Tract Infection (UTI), dehydration, elevated TSH/hypothyroidism. Endocrine consult was done. The patient developed respiratory problems with hazy lungs. Sweat test borderline for CF was done. There were severe episodes of cough with desaturation. The endoscopy revealed immature larynx and esophagitis. The patient was transferred to higher level of care. The diagnosis there was PCP and persistent rotavirus infection from November 2008 to July 2009. There were multiple consults done including genetics. Eventually diagnosis of SCID and the treatment was bone marrow transplants x 2 and chemotherapy. The patient developed large duodenal hematoma secondary to endoscopy. Also developed rash and skin desquamation, and biopsy confirmed graft versus host disease (GVDH) (grade 2); gallbladder sludge, pancreatitis, ascites, delayed gastric emptying and unable to tolerate oral feeding, endoscopy confirmed gut GVDH grade 2. The treatment with multiple courses of antibiotics, steroids, IVIG, chemotherapy, platelet (PLT) and packed red blood cells (PRBC) transfusions. The parent genetic testing indicated both carriers of SCID receptor gene. Eventually, the patient was transferred to specialized hospital for continued rehabilitation. No further information is available.
Age: 0.39
Sex: F
Vaccine: RV5
Symptoms: Combined immunodeficiency, Diarrhoea, Faeces discoloured, Immunodeficiency, Immunoglobulin therapy
Clinical narrative: Information has been received from a physician concerning a 9 month old female patient who on 20-JUL-2009 was vaccinated with a dose of ROTATEQ (manufacturer unknown). It was reported that the patient's mother noted change in stool from mustard yellow to loose, dark green stool on 07-JUL-2009 (this was prior to the 4 month of the vaccine, but presumably she also received her 2 month dose). It was reported that diarrhea continued into her hospitalization, and ultimately was identified as rotavirus, vaccine strain. It was reported that the patient presented to the E.R. and was admitted for further evaluation. The patient was hospitalized from 11-SEP-2009 to 02-OCT-2009. After assessment revealed multiple medical diagnoses, while in hospitalization the patient received IVIG treatment and was to continue after discharge. On 18-SEP-2009 and on 28-SEP-2009, rotavirus test was negative. The discharge diagnoses were severe combined immunodeficiency secondary to ADA deficiency, rhinovirus, rotavirus, periorbital cellulites, and pneumocystes pneumonia. At the time of the report the patient had recovered from the events. No further information is expected.
Age: 0.39
Sex: F
Vaccine: RV5
Symptoms: Periorbital cellulitis, Pneumocystis jiroveci pneumonia, Rhinovirus infection, Rotavirus infection, Rotavirus test positive
Clinical narrative: Information has been received from a physician concerning a 9 month old female patient who on 20-JUL-2009 was vaccinated with a dose of ROTATEQ (manufacturer unknown). It was reported that the patient's mother noted change in stool from mustard yellow to loose, dark green stool on 07-JUL-2009 (this was prior to the 4 month of the vaccine, but presumably she also received her 2 month dose). It was reported that diarrhea continued into her hospitalization, and ultimately was identified as rotavirus, vaccine strain. It was reported that the patient presented to the E.R. and was admitted for further evaluation. The patient was hospitalized from 11-SEP-2009 to 02-OCT-2009. After assessment revealed multiple medical diagnoses, while in hospitalization the patient received IVIG treatment and was to continue after discharge. On 18-SEP-2009 and on 28-SEP-2009, rotavirus test was negative. The discharge diagnoses were severe combined immunodeficiency secondary to ADA deficiency, rhinovirus, rotavirus, periorbital cellulites, and pneumocystes pneumonia. At the time of the report the patient had recovered from the events. No further information is expected.
Age: 16.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Dizziness, Dyspnoea, Headache, Pharyngeal oedema
Clinical narrative: Initial report received from a health care professional on 08 Dec 2009: This patient received FOCETRIA 1 DF on 07 Dec 2009. On the same day, the patient experienced shortness of breath, swelling in throat, headache, and dizziness. The events were reported as life threatening. The events were treated with prednisone (dose unspecified) for 04 days. The outcome was reported as condition improving but the patient still had headache.
Age: 59.0
Sex: M
Vaccine: FLUX(H1N1), FLUX(H1N1), PPV
Symptoms: Blood pressure increased, Chills, Dyspnoea, Injection site erythema, Joint range of motion decreased
Clinical narrative: THIS IS A FOLLOW-UP TOA PREVIUOSLY SUBMITTED VAERS REPORT 378545-1. Immunization record and ER/clinic entries note PNEUMOVAX given on event date. Pt verified that PNEUMOVAX was given in the effected arm, and he received H1N1j on same day in the other arm. Within 4 hours of vaccination receipt, noted pain from right shoulder down triceps region and toward chest to level of lower ribs. Pain described as constant sharp, burning pain. Pain severity rated as 9/10. Unable to abduct R)UE d/t pain. Difficulty breathing secondary to pain. Patient denied significant redness, warmth, induration or swelling at the vaccination sites. No weakness or numbness/tingling of R)UE. Evaluated in ED on afternoon of vaccine receipt. Dx of local reaction to immunization; treated with BENADRYL and PERCOCET. Follow-up on 28 Jan noted symptom Improvement, but still having pain with AROM of R)UE. Complete resolution of symptoms by 3 February.
Age: 59.0
Sex: M
Vaccine: FLUX(H1N1), FLUX(H1N1), PPV
Symptoms: Mobility decreased, Musculoskeletal pain, Nausea, Pain in extremity, Pyrexia
Clinical narrative: THIS IS A FOLLOW-UP TOA PREVIUOSLY SUBMITTED VAERS REPORT 378545-1. Immunization record and ER/clinic entries note PNEUMOVAX given on event date. Pt verified that PNEUMOVAX was given in the effected arm, and he received H1N1j on same day in the other arm. Within 4 hours of vaccination receipt, noted pain from right shoulder down triceps region and toward chest to level of lower ribs. Pain described as constant sharp, burning pain. Pain severity rated as 9/10. Unable to abduct R)UE d/t pain. Difficulty breathing secondary to pain. Patient denied significant redness, warmth, induration or swelling at the vaccination sites. No weakness or numbness/tingling of R)UE. Evaluated in ED on afternoon of vaccine receipt. Dx of local reaction to immunization; treated with BENADRYL and PERCOCET. Follow-up on 28 Jan noted symptom Improvement, but still having pain with AROM of R)UE. Complete resolution of symptoms by 3 February.
Age: 59.0
Sex: M
Vaccine: FLUX(H1N1), FLUX(H1N1), PPV
Symptoms: Dyspnoea, Injected limb mobility decreased, Injection site pain, Musculoskeletal chest pain
Clinical narrative: THIS IS A FOLLOW-UP TOA PREVIUOSLY SUBMITTED VAERS REPORT 378545-1. Immunization record and ER/clinic entries note PNEUMOVAX given on event date. Pt verified that PNEUMOVAX was given in the effected arm, and he received H1N1j on same day in the other arm. Within 4 hours of vaccination receipt, noted pain from right shoulder down triceps region and toward chest to level of lower ribs. Pain described as constant sharp, burning pain. Pain severity rated as 9/10. Unable to abduct R)UE d/t pain. Difficulty breathing secondary to pain. Patient denied significant redness, warmth, induration or swelling at the vaccination sites. No weakness or numbness/tingling of R)UE. Evaluated in ED on afternoon of vaccine receipt. Dx of local reaction to immunization; treated with BENADRYL and PERCOCET. Follow-up on 28 Jan noted symptom Improvement, but still having pain with AROM of R)UE. Complete resolution of symptoms by 3 February.
Age: 24.0
Sex: F
Vaccine: HEPA, HPV4, TDAP, VARCEL, VARCEL
Symptoms: Fatigue, Injection site erythema, Injection site induration, Skin warm
Clinical narrative: Here for 2nd varicella vaccine within 10 hours vaccine started getting red - warm to touch. Used Benadryl prior to vaccine and every 6 hours after. Redness, tenderness increased - 27 hours later, O.V. Redness measured 60mm x 60mm, warm tender. Comfort measures continued.
Age: 24.0
Sex: F
Vaccine: HEPA, HPV4, TDAP, VARCEL, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: Here for 2nd varicella vaccine within 10 hours vaccine started getting red - warm to touch. Used Benadryl prior to vaccine and every 6 hours after. Redness, tenderness increased - 27 hours later, O.V. Redness measured 60mm x 60mm, warm tender. Comfort measures continued.
Age: 41.0
Sex: F
Vaccine: FLU(H1N1), FLUX(H1N1)
Symptoms: Blood test, Computerised tomogram, Facial palsy
Clinical narrative: Initial report received on 19 February 2010 from the patient. A 42-year-old female patient had received a second intramuscular left deltoid injection of an H1N1 vaccine (trade name, manufacturer name, and lot number not reported) on either 09 or 16 December 2009. The patient had also received a seasonal flu vaccine (trade name, manufacturer name, lot number, route and site of administration not reported) on an "unknown" date. The seasonal flu vaccine was written in section number 14 on the VAERS form. Approximately 5-6 weeks post-vaccination, also reported as being on 03 February 2010, the patient developed "complete paralysis." She was unsure as to when symptoms first began appearing, and required a doctor visit, however the result of that visit was not provided. It was also not reported whether the patient completed any diagnostic tests, or if any treatment or hospitalization was required. The patient stated she is healthy, and denied any illnesses at time of vaccination. She also denied having any allergies or medical conditions; however concomitant medication includes Accutane therapy. The patient denied having any adverse events with prior vaccinations. At the time of this report, the patient had not recovered. Documents held by sender: None.
Age: 41.0
Sex: F
Vaccine: FLU(H1N1), FLUX(H1N1)
Symptoms: Paralysis
Clinical narrative: Initial report received on 19 February 2010 from the patient. A 42-year-old female patient had received a second intramuscular left deltoid injection of an H1N1 vaccine (trade name, manufacturer name, and lot number not reported) on either 09 or 16 December 2009. The patient had also received a seasonal flu vaccine (trade name, manufacturer name, lot number, route and site of administration not reported) on an "unknown" date. The seasonal flu vaccine was written in section number 14 on the VAERS form. Approximately 5-6 weeks post-vaccination, also reported as being on 03 February 2010, the patient developed "complete paralysis." She was unsure as to when symptoms first began appearing, and required a doctor visit, however the result of that visit was not provided. It was also not reported whether the patient completed any diagnostic tests, or if any treatment or hospitalization was required. The patient stated she is healthy, and denied any illnesses at time of vaccination. She also denied having any allergies or medical conditions; however concomitant medication includes Accutane therapy. The patient denied having any adverse events with prior vaccinations. At the time of this report, the patient had not recovered. Documents held by sender: None.
Age: 69.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Ophthalmological examination
Clinical narrative: Information has been received from a pharmacist concerning a 69 year old male who on 11-DEC-2008 was vaccinated with a dose of ZOSTAVAX (Merck) (lot # not reported), 194 ug, subcutaneously. Concomitant therapy included LIPITOR, CELEBREX, warfarin, PRILOSEC and metoprolol succinate. Between January and February 2009, several weeks after receiving the vaccine the patient developed severe case of ocular shingles. The patient was referred to ophthalmologist who treated the patient with oral antiviral therapy which was still ongoing in February 2010. At the time of the report the patient had not recovered from severe case of ocular shingles. Various tests were performed by ophthalmologist but the results were not provided. Severe case of ocular shingles was considered to be disabling and other important medical event. A Product Quality complaint has been filed. Additional information has been requested.
Age: 41.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Contusion, Pruritus, Rash, Urticaria
Clinical narrative: broke out in hives real bad left some bruising marks that starting to disappear now where i can see them lasted for like 3 days took allergy pill helped stop itching still have some bumps on back arms face.
Age: 11.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Varicella Like eruption
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Left arm from shoulder to elbow is red and itchy. 2/24/10 Red, hot, swollen area L deltoid 7x9 cm. To use ice and BENADRYL.
Age: 2.0
Sex: M
Vaccine: DTAP, HEP, HIBV, MMR, PNC, VARCEL
Symptoms: Injection site nodule
Clinical narrative: Patient in on 2-8-10 updated on shots. Mother called 2/24/10 states 2 days ago patient developed knot next to injection site. (L)A SQ. She denies any redness, warmth or other nodules or swelling in the arm elbow or hand of the left arm. Patient mother concerned she has no insurance. I spoke with our health officer about the situation. He suggested maybe it being a hematoma will observe. Mother called 2/25/10 and said knot is softened and starting to dry out. She was informed to call if any questions or concerns and would f/u in 2 weeks.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site pruritus, Injection site swelling
Clinical narrative: Swelling to left upper arm & Itching. Antibiotics prescribed. Ice for swelling. Benadryl as needed for severe itching.
Age: 19.0
Sex: F
Vaccine: FLU(H1N1), FLU3, HPV4
Symptoms: Dyskinesia, Muscle rigidity, Nausea, Syncope
Clinical narrative: Pt received vaccines in supine position. Pt received TIV in L arm. Pt received HPV in R arm c/o nausea, CMA placed a cold pack on pt's neck and took sip of H2O and asked RN to come into room. Held off giving H1N1 for 5-10 minutes, at pt's insistence gave H1N1 and within seconds pt developed syncope became rigid then jerking of arms and legs with paused breathing for 15 sec. Pt responded quickly alert and oriented.
Age: 2.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: 5x2 cm red area that was warm to palp and tender, no drainage.
Age: 0.54
Sex: M
Vaccine: TDAP
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: No adverse event.
Age: 63.0
Sex: M
Vaccine: FLU3
Symptoms: Immediate post-injection reaction, Injected limb mobility decreased, Injection site haematoma, Injection site pain, Musculoskeletal pain
Clinical narrative: My husband, came into the pharmacy for his flu shot on 10/5/09. When they gave him the shot they injected it right into his shoulder joint. He said it was the most painful shot he has ever had. It continued to be painful for quite some time & he went to the doctor on 10/27/2009 due to how painful his shoulder was from this. At that time the doctor said he has a hematoma from the injection & put him on antibiotics & steroids (all filled @ your pharmacy as all his meds are). He was still having a lot of pain & restricted range of motion & went back to the doctor on 11/14/2009 & was scheduled for a MRI at hospital on 11/18/2009. Then he was referred to Orthopedics & was seen on 12/28/2009. We were told the injection tore his rotator cup & Physical therapy was suggested & he followed through with that @ hospital as well. All of these appointments & therapy came up to $4,209.90. Just from an injection being given improperly & we feel we should be reimbursed for these expenses at the very least not to mention the pain & suffering from this.
Age: 63.0
Sex: M
Vaccine: FLU3
Symptoms: Rotator cuff syndrome, Wrong technique in drug usage process
Clinical narrative: My husband, came into the pharmacy for his flu shot on 10/5/09. When they gave him the shot they injected it right into his shoulder joint. He said it was the most painful shot he has ever had. It continued to be painful for quite some time & he went to the doctor on 10/27/2009 due to how painful his shoulder was from this. At that time the doctor said he has a hematoma from the injection & put him on antibiotics & steroids (all filled @ your pharmacy as all his meds are). He was still having a lot of pain & restricted range of motion & went back to the doctor on 11/14/2009 & was scheduled for a MRI at hospital on 11/18/2009. Then he was referred to Orthopedics & was seen on 12/28/2009. We were told the injection tore his rotator cup & Physical therapy was suggested & he followed through with that @ hospital as well. All of these appointments & therapy came up to $4,209.90. Just from an injection being given improperly & we feel we should be reimbursed for these expenses at the very least not to mention the pain & suffering from this.
Age: 43.0
Sex: M
Vaccine: TDAP
Symptoms: Oedema peripheral, Swelling face, Urticaria
Clinical narrative: Hives-entire body, face/hands-swollen, no trouble breathing. All symptoms began morning after IM. Medrol dose pak, epi pen, ZYRTEC, Rx given.
Age: 0.35
Sex: F
Vaccine: DTAPIPVHIB, PNC, RV5
Symptoms: Injection site nodule
Clinical narrative: Both legs = 1 inch Diameter know under the skin. Neither site painful.
Age: 28.0
Sex: F
Vaccine: FLU3
Symptoms: Injected limb mobility decreased, Musculoskeletal pain
Clinical narrative: limited ROM in upper et lower arm, pain in LT shoulder area -unsure if pain is from shot or if pulled a muscle while taking a piece of equipment apart
Age: 2.0
Sex: M
Vaccine: DTAP, HIBV, MMR, PNC, VARCEL
Symptoms: Crying, Injection site erythema, Injection site swelling
Clinical narrative: Patient 19 mos here bec redness & swelling on both legs. Mom has been giving Benadryl, alternating Motrin & Tylenol. Mom reports that px was crying non stop last night. Px got MMR #1, PREVNAR #4 & Varicella #1 on right leg, DTAP #4 & Hib #4 on the L leg. Mom reports that px did not have any reaction w/ his previous vaccines. This is the first time px got MMR & Varicella.
Age: 18.0
Sex: F
Vaccine: FLU(H1N1), FLU3
Symptoms: Blood immunoglobulin A, Complement factor C3, Full blood count normal, International normalised ratio normal, Laboratory test normal
Clinical narrative: A rash like reaction on legs, small pin head size red bumps, no itching or pain.
Age: 18.0
Sex: F
Vaccine: FLU(H1N1), FLU3
Symptoms: Prothrombin time normal, Rash erythematous, Urine analysis normal
Clinical narrative: A rash like reaction on legs, small pin head size red bumps, no itching or pain.
Age: 1.02
Sex: M
Vaccine: FLU(H1N1), FLU3, HIBV, MMR
Symptoms: Petechiae, Platelet count decreased
Clinical narrative: Petechiae, seen 2/17/10 on torso
Age: 29.0
Sex: M
Vaccine: FLU(H1N1), SMALL
Symptoms: Injection site erythema, Injection site rash
Clinical narrative: Came in to immunization clinic for Smallpox vaccination and other deployment shots on 1 Feb 2010. 21 Feb 10 at night noticed red swollen marks around smallpox site and spreading thru left chest. Seen MD off base but returned to base for evaluation. Came into clinic the next day 22Feb10. Advised to be grounded by Flight medicine.
Age: 36.0
Sex: M
Vaccine: ANTH, FLU(H1N1), FLU3, HEPAB, TYP
Symptoms: Dizziness, Hyperhidrosis, Vision blurred
Clinical narrative: Pulse: 56 after shots. Pt states felt sweaty and had blurred vision. Received 5 vaccines today on both arms. 10 mins after pt. states feels a little better. Did not pass out. Not nauseated just light headed. Pt. states gets this feeling mostly after giving blood. and Pulse 15 mins later: 68
Age: 71.0
Sex: F
Vaccine: VARZOS
Symptoms: Gait disturbance, Muscle spasms, Myalgia, Pain in extremity
Clinical narrative: Information has been received from a 71 year old female with allergic reaction to penicillin, sulfonamide and codeine, who on 14-DEC-2009 was vaccinated with a dose of ZOSTAVAX (Oka/Merck), in her hip rather than in her arm because the nurse said it would be less painful. No lot number was provided. The next day on 15-DEC-2009 the patient started experiencing pain in both of her calves. In January the pain started to go up to the thigh area of both legs, but was worse in the right leg. She still had difficulty walking and it had worsened. The pain had been worse in her right leg since onset of pain in December. Since having the injection she had had muscle pain in her leg and calf, kind of like a charlie horse, which was severe enough that she had difficulty walking. Thus far she had not seen a physician regarding the pain she was experiencing. The patient had not recovered at time of report. Muscle pain, pain in extremity and difficulty walking were considered to be disabling by the consumer. No further information is available.
Age: 5.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: SWELLING AND REDNESS AT INJECTION SITE PER URGENT CARE 5 INCHES BY 6 INCHES
Age: 76.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Dizziness, Dysphonia, Nausea, Oropharyngeal pain
Clinical narrative: Pt was asked to wait 15 min. after H1N1 vaccine given. Within 15-20 minutes, patient c/o dizziness, nausea, throat sore and hoarseness. EMT called one dose of Epinephrine 1:1000 given sc (0.3cc) vitals prior to epinephrine BP185/95, 72,20 96.6 F
Age: 3.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Rash macular
Clinical narrative: Right arm, broken out in pinkish/purply area; under arm blotchy reddish/pink; right arm noticably larger (swollen) than left arm; no c/o pain or discomfort; warm to touch (parent has pictures, taking to Dr. for chart); had no trouble moving the arm; "back to normal on Saturday morning"; ROM is normal currently
Age: 5.0
Sex: M
Vaccine: FLU3, FLUN(H1N1)
Symptoms: Compulsions
Clinical narrative: mom states that a "few days after the flu vaccines he started having a compulsion to roll up  the pant legs on his trousers." This never happened before.
Age: 60.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Feeling abnormal, Headache, Nausea, Pain, Pyrexia
Clinical narrative: states administered H1N1 vaccine 2-10-10 then by Friday 2-12-10 "began to feel badly c/o fever, congestion, headache, body aches, and nausea. Stated no fever today - 2-18-10. However, still feels dull H/A and body aches. Noted took OTC cold medicine. As of 2-18-10 still dull H/A, body aches, some congestion.
Age: 60.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Upper respiratory tract congestion
Clinical narrative: states administered H1N1 vaccine 2-10-10 then by Friday 2-12-10 "began to feel badly c/o fever, congestion, headache, body aches, and nausea. Stated no fever today - 2-18-10. However, still feels dull H/A and body aches. Noted took OTC cold medicine. As of 2-18-10 still dull H/A, body aches, some congestion.